Deep TMS for major depression resistant to medication
Deep TMS at Neuroperforma – A cutting-edge technology for treating major depression
At Neuroperforma, our mission is to make the best advancements in neurotechnologies accessible, providing our clients with clinically recognized solutions to improve their well-being and transform their quality of life.
Among these solutions, we are proud to be one of the few private clinics in Quebec to offer Deep Transcranial Magnetic Stimulation (Deep TMS), an innovative approach recognized worldwide.

What is Deep TMS (Deep TMS)?
Non-invasive, safe, and medication-free, Deep TMS reactivates key brain regions responsible for mood and motivation.
Thanks to BrainsWay's cutting-edge technology and the intensive SWIFT protocols, treatment for major depression achieves clinically significant results, with the potential for a faster response than conventional approaches.
Standard rTMS vs. Deep TMS : what's the difference?
Classic rTMS
Classic rTMS using standard protocols utilizes a figure-8 coil to stimulate superficial areas of the brain, which can be effective in certain cases of depression.
- Number of clinic visits: 36
- Response rate: 40–50%
- Remission rate: 25–30%
- Treatment period: 9 weeks
Deep TMS with Intensive SWIFT Protocol (Neuroperforma)
Deep TMS uses a patented H-Coil helmet, allowing stimulation of deeper and broader regions of the brain. Combined with the SWIFT intensive treatment protocol cleared by the FDA in September 2025, Neuroperforma offers a treatment that is highly effective, fast, and durable, particularly for cases of treatment-resistant major depression.
- Number of clinic visits: 10
- Response rate: 87.8%
- Remission rate: 78%
Source: Hanlon CA et al., Brain Stimulation, 2026. DOI: 10.1016/j.brs.2026.103050. Results are based on patients who completed the protocol (n=41). Individual results may vary.
How does Deep TMS work on depression?
When antidepressants are no longer effective, the brain can remain stuck in disrupted activity patterns: some regions are under-stimulated while others are overactive.
Deep TMS sends magnetic pulses that generate electrical activity capable of:
Achieve remission in an average of 21 days.
While most clinics and hospitals offer a traditional treatment spread over 9 weeks, the intensive SWIFT protocol used by Neuroperforma allows remission from depression in an average of 21 days.
This FDA-cleared protocol provides the following results:
- 87.8% treatment response rate (minimum 50% reduction in symptoms)
- 78% remission rate (non-depressed after treatment)
- 21 days on average to reach remission (Source: Hanlon CA et al., Brain Stimulation, 2026)
Source: Hanlon CA et al., Brain Stimulation, 2026. DOI: 10.1016/j.brs.2026.103050. Results are based on patients who completed the protocol (n=41). Individual results may vary.
Result? Our patients benefit from an effective and rapid treatment, supervised by a specialized team.
Pricing and added value
Invest in your well-being
At Neuroperforma, every Deep TMS process is supervised by professionals and based on a rigorous clinical approach.
What's included
Insurance coverage
We provide quotes and receipts for your reimbursement process
Who is it for?
This protocol is intended for adults with treatment-resistant major depression. If you have tried several antidepressants without satisfactory results, or if side effects have become too burdensome, Deep TMS could be a new solution.
Treatment-resistant major depression
TMS for veterans – Care that may be fully covered
Based on your eligibility with Medavie Blue Cross
At Neuroperforma, we are proud to support veterans and former service members who have served our country. Thanks to programs offered by Medavie Blue Cross, Transcranial Magnetic Stimulation (TMS) treatments may be fully covered for eligible veterans.
Our specialized team supports each veteran every step of the way—from the initial evaluation to treatment follow-up—in collaboration with Veterans Affairs Canada and the insurance provider.
Are you a veteran?
Contact us today to schedule your free evaluation and begin a care journey tailored to your needs.
Book a free consultationWhy choose Deep TMS at Neuroperforma?
FAQ – Transcranial Magnetic Stimulation (rTMS / Deep TMS)
No. Magnetic stimulation is non-invasive and painless. You may feel slight tingling or a tapping sensation on the scalp during the session, but this disappears at the end. Some patients may experience jaw muscle contraction during treatment.
No. rTMS is done without anesthesia, sedation or medication. You are awake and can resume your activities immediately afterward.
Each treatment lasts approximately 10 minutes. Treatments are spaced with a 50-minute rest period between each session.
The SWIFT protocol is an intensive treatment protocol for major depression cleared by the FDA on September 16, 2025. It includes 6 half-days in clinic, where 1 treatment is administered every hour, for a total of 5 treatments per visit (30 treatments in 6 days). After this intensive phase, patients attend 1 clinic visit per week, where 2 treatments are administered. This results in a total of 38 treatments over 5 weeks, spread across 10 clinic visits. This protocol demonstrates significantly higher effectiveness compared to traditional protocols, where 36 treatments are spread over 9 weeks.
The SWIFT intensive protocol is offered at a cost of $7,960. This price includes the evaluation with the psychiatrist, 38 treatments (10 minutes each), access to a private rest room, snacks and healthy lunches, support from the professional team, and post-treatment follow-ups.
No. The Quebec Health Insurance Board (RAMQ) does not cover this service in private clinics.
Yes, some private insurances offer partial or full reimbursement, depending on your contract. Additionally, certain specific programs (e.g., Veterans and Canadian Armed Forces) may cover the treatment.
Deep TMS is particularly indicated for major depression.
Improvements are generally felt after the 3rd or 4th half-day of intensive treatment. Some individuals experience a more gradual improvement that unfolds in the days and weeks following the end of the intensive phase.
Yes. Studies show that rTMS effects are stable long-term. In some cases, a maintenance protocol (a few additional sessions per year) may be recommended.
Side effects are rare and generally mild: slight headaches, mild jaw pain or discomfort, feeling of fatigue after the session. These effects usually disappear quickly without treatment.
Antidepressants act on brain chemistry, but can cause significant side effects. rTMS acts directly on the brain's electrical activity to rebalance mood circuits, without medication and without systemic side effects.
Traditional rTMS only stimulates superficial layers of the brain. Deep TMS (Neuroperforma) reaches deeper and wider areas thanks to H-Coil technology → better efficacy and faster results.
Yes, but we include it free of charge through a video conference meeting with our affiliated physician.
No. rTMS can be combined with your current treatments. Any medication adjustment should be discussed with your doctor.
rTMS is safe, but certain conditions require prior evaluation (e.g., metal implants in the head, cardiac pacemakers). An initial interview serves to verify your eligibility.
Currently, the intensive rTMS protocol is offered only at the Neuroperforma clinic in Saint-Hubert.
No. Snacks and beverages are included for patients, but accommodation is not. We recommend that patients coming from outside the area book a nearby hotel.
Yes. A companion can be admitted with you in your rest room. Please note that meals are not provided for them.
Ready to take the next step?
Your first consultation is free and without obligation.
Book an appointment nowIndividual results may vary. The data presented is from Hanlon CA et al., Brain Stimulation, 2026 (DOI: 10.1016/j.brs.2026.103050). Results are based on patients who completed the protocol (n=41). This treatment is intended for adults suffering from medication-resistant major depression, under medical supervision. Deep TMS does not replace a psychiatric evaluation. This treatment is not covered by RAMQ. BrainsWay H-Coil technology approved by Health Canada since 2013.